Stock Update (NYSE:CVS): CVS Health Research Institute Study Shows 11.4 Percentage Point Improvement in Medication Adherence Among Patients in Specialty Connect™ Pilot

[PR Newswire] – WOONSOCKET, R.I., Jan. 29, 2016 /PRNewswire/ — New research published by the CVS Health (NYSE: CVS) Research Institute showed a significant improvement in adherence to specialty medications for patients … Read more on this. CVS Health Corporation (CVS) , with a current market cap of $106.35B, opened at $94.21. Looking at the stock, its one day range is $93.21 to $95.84 and has traded between $81.37 and $113.65 over the past year. Priced at 18.25x this year’s forecasted earnings, CVS shares are relatively expensive compared to the industry ’s 7.78x forward p/e ratio. And for income investors, the company pays shareholders $1.70 per share annually in dividends, yielding 1.81%. Consensus earnings for the current quarter by the 22 sell-side analysts covering the stock is an estimate of $1.53 per share, which would be $0.32 better than the year-ago quarter and a $0.02 sequential increase. What we find to be interesting is that the full-year EPS estimate of $5.17 is a $0.66 improvement when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $41.12 Billion. If reported, that would be a 10.96% increase over the year-ago quarter. Recently, Robert W. Baird Initiated CVS at Outperform (Jan 22, 2016). Previously, Goldman downgraded CVS from Buy to Neutral. With the above information in mind, readers should note that the average price target is $114.82, which is 21.88% above where the stock opened this morning. See more in (NYSE:CVS) Similar Articles: Stock Update (NYSE:CVS): CVS Health Research Institute Study Finds that Initial Prescription Fills Can Accurately Predict Long-term Medication Adherence Company Update: CVS Caremark Corporation (NYSE:CVS) – CVS Health Research Institute Publishes First Findings that Show Narrow Pharmacy Networks Can Help Improve Medication Adherence Market Update (NYSE:CVS): CVS Health Launches ScriptSync(TM) to Make Medication Adherence Easier for Patients who Have Multiple Prescriptions